Showing 20 of 98 recruiting trials for “Squamous cell carcinoma of the esophagus”
Neoadjuvant QL1706 Therapy for ESCC
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
👨⚕️ Hui Liu, Professor, Sun yat-sen universtiy cancer center📍 1 site📅 Started Apr 2025View details ↗
A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
RecruitingNCT07088354 ↗
Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy
Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy
👨⚕️ Jinming Yu, Dr., Shandong Cancer Hospital and Institute📍 1 site📅 Started Jan 2025View details ↗
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma
👨⚕️ Yunpeng Zhao, doctor, The Second Qilu Hospital of Shandong University📍 1 site📅 Started Dec 2024View details ↗
Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)
Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
👨⚕️ Zhihao Lu, MD, Peking University Cancer Hospital & Institute📍 1 site📅 Started Nov 2024View details ↗
Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
👨⚕️ Tao Jiang, Dr, Tangdu hospital, The air force military university📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06710665 ↗
Tumor Regression Grade As Predictor of Adjuvant Therapy
👨⚕️ Bin Zheng, Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fu📍 1 site📅 Started Oct 2024View details ↗
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study
RecruitingNCT06561178 ↗
Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
👨⚕️ Hong Yang, M.D.;Ph.D., Sun Yat-Sen University Cancer Center📍 1 site📅 Started Aug 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →